MoneyWorks4Me

Dr. Lal PathLabs informs about analyst meet

07 Mar 2022 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that details of proposed schedule of Analyst/Investor meeting to be held on March 08, 2022 is attached.

The above information is a part of company’s filings submitted to BSE.

Peers